Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Ut Health San Antonio Appoints Georg Aue As Director of Stem Cell Transplant Program

PRIVATEAug 24, 2026•about 5 hours ago

Position

Director

Company

UT Health San Antonio

Georg Aue
San AntonioBiotechnologyHealth CareEducationMedical

Description

UT Health San Antonio has appointed Georg Aue, MD, PhD, MBA, as the director of the Stem Cell Transplant and Cellular Therapy Program at the Mays Cancer Center. He will also serve as the inaugural director of the new Stem Cell Transplant and Cellular Therapy Unit.

Company Information

Company

UT Health San Antonio

Location

San Antonio, Texas, United States

About

The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is a leading academic medical center with a focus on research, education, and healthcare/clinical enterprise.

Don't miss UT Health San Antonio's next move

Get an email the moment UT Health San Antonio changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for UT Health San Antonio's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

UT Health San Antonio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.